Interleukin-6 Levels in Tension Headache Patients
dc.contributor.author | Koçer, Abdulkadir | |
dc.contributor.author | Koçer, Emel | |
dc.contributor.author | Memişoğulları, Ramazan | |
dc.contributor.author | Domaç, Füsun M. | |
dc.contributor.author | Yüksel, Hatice | |
dc.date.accessioned | 2020-04-30T23:18:32Z | |
dc.date.available | 2020-04-30T23:18:32Z | |
dc.date.issued | 2010 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | Kocer, Abdulkadir/0000-0003-2866-555X | en_US |
dc.description | WOS: 000281818200006 | en_US |
dc.description | PubMed: 20664340 | en_US |
dc.description.abstract | Objective: Cytokines are pain mediators in neurovascular inflammation. This study examined interleukin 6 (IL-6) levels in the serum of tension-type headache (TTH) patients, to determine if inflammation plays a role in the pathogenesis of this condition. Methods: Serum IL-6 levels were studied in 42 patients and 37 healthy controls from the same region. Of the patients, 20 (47.6%) experiencing TTH less than 15 days per month were placed in episodic tension-type headache (ETTH) group, and 22 (52.3%) with TTH more than 15 days per month were placed in chronic tension-type headache (CTTH) group. Results: The IL-6 level was significantly higher in the patients than in the controls. The IL-6 level of CTTH patients was higher than the controls (P < 0.01). The IL-6 level was similar between ETTH and CTTH patients. Correlation analysis revealed a positive relationship only between age and IL-6 level in the patients. Conclusions: CTTH and ETTH patients had an elevated serum IL-6 level compared with controls. Therefore, we believe that IL-6 may be involved in pain induction or inflammatory mechanisms in TTH. Furthermore studies of the possible connection between chronicity of headaches and cytokine levels are needed. | en_US |
dc.identifier.endpage | 693 | en_US |
dc.identifier.issn | 0749-8047 | |
dc.identifier.issn | 1536-5409 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 690 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/3391 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000281818200006 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Clinical Journal Of Pain | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | tension type headache | en_US |
dc.subject | interleukins | en_US |
dc.subject | pain | en_US |
dc.subject | inflammation | en_US |
dc.title | Interleukin-6 Levels in Tension Headache Patients | en_US |
dc.type | Article | en_US |